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Objectives: Mother to child transmission of HIV remains a concern despite the introduction of ARVs 
during pregnancy. The mechanism by which HIV transmission across the placenta takes place needs to 
be evaluated.  
The placenta is a selective filter and the only barrier between the developing fetus and the mother. 
Should the implicated proteins of HIV transmission be found in and on placental tissue, it is plausible 
that these proteins provide the needed pathway for HIV infection of the fetus. 
Orthodox mechanisms of transmission involving the CD4-CCR5 interaction have been previously 
looked at in placenta. This study aims to evaluate expression of these key proteins implicated in the 
transmission of HIV transmission across placental exchange villi. 
 
Study Design: Following post institutional ethical approval, 60 archived paraffin embedded placental 
tissue blocks were used for this study. Tissue samples being examined were obtained from 
normotensive HIV positive and negative mothers who delivered at a rural district hospital in Kwa-Zulu 
Nata. The tissue samples were immunohistochemically stained with target antibodies (CD68, DC-SIGN 
and CD1a) and analysed using light microscopy. This was followed by morphometric analysis with 
subsequent statistical analysis.  
 
Results: Analysis of the demographic data showed a significant difference between the placental weight 
(p = 0.005), with HIV positive placentae having a greater weight (517.33±81.59) than HIV negative 
placentae (457.10±77.81). 
There was no significant difference in the positive immunoexpression of the CD68, DC-SIGN and 
CD1a markers noted between the HIV negative and positive groups; nor within the HIV positive 
subgroups. 
DC-SIGN expression was noted on immune cells as well as syncytiotrophoblast layers of conducting 
and exchange placental villi. CD68 expression on the immune cells showed no difference in expression 
between HIV positive and HIV negative groups. CD1a expression was not seen in the placental villi 
nor the immune cells of the different groups. 
 
Conclusion: We have seen that the number of cells which express the CD68 and DC-SIGN markers 
remain constant regardless of HIV status and tend to increase from placentation to gestation. Further 





Over three decades has been dedicated to finding a cure and eradicating human immunodeficiency virus 
and acquired immunodeficiency syndrome (HIV/AIDS). Extensive research has been carried out all over 
the world in an effort to understand the make-up of this resilient virus and the mechanism by which it 
evades all efforts of neutralization (Kasahara, 2011). The retaliation of the immune system and its constant 
bombardment with drugs has honed viral evolution by selecting phenotypes that mitigate such onslaught.  
Antigenic variation and production of immune evasion or sequestering proteins are some ways in which 
HIV continues to plague humans (Kasahara, 2011).  
 
Mutability of viral RNA is an important key to the success of this pathogen (Iyidogan and Anderson, 2014). 
In light of this and the global statistics of HIV and its impact on future generations, public health strategies 
have focused on preventative measures to eliminate current transmission rates. While such strategies are 
paramount and will eventually reduce mortality rates, understanding the pathophysiology and transmission 
of HIV is of immediate concern, especially in the most vulnerable groups: pregnant women and their babies 
(Tiemessen and Kuhn, 2006).   This study seeks to better understand the mechanism of transmission of 
HIV in these groups by examining immune cells targeted by HIV and the placenta, through which in utero 
transmission occurs. Molecules identified on the immune cells include the Cluster of Differentiation 68 
(CD68), Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Non-Integrin (DC-SIGN) 
and Cluster of Differentiation 1a (CD1a). Due to the biological importance as well as their importance in 
HIV transmission, these molecules have been of interest and have previously documented individually, 
especially that of DC-SIGN (Boily-Larouche et al., 2012; Pillay et al., 2014; Tassaneetrithep et al., 2003) 
and CD68 (Kim et al., 2007). However, there has not yet been a study which evaluates the expression of 
these markers in consecutive sections of placental tissue samples.  This study aims to immunolocalize these 
proteins and compares their expression in HIV positive and HIV negative patients. Such understanding 
may add valuable insight into mother to child transmission and maternal and fetal mortality.   
 
1.2. Literature Review 
1.2.1. Maternal Mortality 
Maternal mortality remains a global concern. Defined as death due to complications from pregnancy or 
childbirth (Tenth Interim Report on Confidential Enquiries into Maternal Deaths in South Africa, 2011), 
it has seen dramatic rise in the last 25 years (Saving Mothers 2008-2010: Fifth Report on the Confidential 
Enquiries into Maternal Deaths in South Africa., 2010) due to non-pregnancy related infections (NPRI). 
However, the latest statistics have indicated a slight decrease in the percentage of maternal deaths attributed 
to NPRI’s (Saving Mothers 2011- 2013: Sixth Report on the Confidential Enquiries into Maternal Deaths 




The Millennium Development Goals (MDG) were established and agreed upon at the Millennium Summit 
of the United Nations in 2000 in an attempt to address key health concerns plaguing countries around the 
world. The MDG’s have resulted in the reduction of global maternal mortality by 45 percent. 
Unfortunately, many developing countries have not achieved these targets, including South Africa. In lieu 
of this, the World Health Organization has developed the Sustainable Development Goals. This has offered 
countries the opportunity to work towards the betterment of their circumstances over the next fifteen years 
by setting goals with multiple targets geared towards various issues of global concern. Latest statistics 
released by the United Nations states that the maternal mortality ratio in developing countries is still 
fourteen times higher than developed regions; with only half the women having access to the recommended 
amount of antenatal care which they need. The Sustainable Development Goals aim to reduce the maternal 
mortality ratio to less than 70 deaths per 100 000 live births as well as end the AIDS epidemic by the year 
2030 (UN, 2015). 
 
According to the World Health Organization, it is approximated that over 800 women die per day due to 
pregnancy or child related complications (WHO, 2014). The majority of these deaths are concentrated to 
two main areas; namely Sub-Saharan Africa and Asia (WHO, 2014). A staggering 91% of deaths occur in 
Sub-Saharan Africa, which has the highest maternal mortality ratio at 510 deaths per 100 000 live births; 
amounting to approximately 179 000 maternal deaths per year (WHO et al., 2014). Statistics released as 
part of the Sixth Report on the Confidential Enquiries into Maternal Deaths in South Africa (Saving 
Mothers 2011- 2013: Sixth Report on the Confidential Enquiries into Maternal Deaths in South Africa, 
2015) reveal that almost 35% of maternal deaths are due to Non-Pregnancy Related Infections (NPRI’s), 
with HIV being the most prevalent. This can be clearly seen in Figure 1.1. With HIV being so rife in 































HIV is a lentivirus belonging to a subgroup of viruses known as Retroviridae. Lentiviruses are single-
stranded, enveloped RNA viruses which have been said to be gene transfer agents and have the ability 
to deliver a substantial amount of viral DNA into non-dividing cells (Yamashita and Emerman, 2006). 
Lentiviruses appear to have a specific tropism for macrophages which essentially then acts as a major 
reservoir for the virus in an infected individual (Strauss and Strauss, 2002). HIV also infects non-
dividing cells such as resting CD4+ T cells (Naldini, 1998; Yamashita and Emerman, 2006). The ability 
of HIV to invade these cells has brought about the belief that this mechanism of infection is vital to the 
transmission of the various subtypes of HIV, for example  HIV-1 , and the spread of the virus (Fassati, 
2006). In this way, Lentiviruses are able to establish life-long, chronic infections that is not able to be 
cleared by the typical response of the immune system (Strauss and Strauss, 2002).  
 
HIV has various subtypes with varying degrees of severity of disease. Of concern are HIV-1 and HIV-
2 subtypes. The HIV-1 subtype is considered to be the main subdivision of HIV due to it accounting 
for more than 95% of all HIV infections worldwide. The HIV-1 subtype is the general strain when 
referring to global HIV infection; unlike HIV-2 which is localized to West Africa (Nyamweya et al., 
2013). Unlike its counter-subtype HIV-2, HIV-1 has a much higher virulence as well as a faster rate of 
disease progression (Marlink et al., 1994; Nyamweya et al., 2013). 
Figure 1.1. Depictions of various causes of global maternal mortality extracted from the Saving 
































The primary targets of HIV-1, namely CD4 cells, dendritic cells and macrophages, are involved in the 
immune response of the body against pathogens such as HIV. By attacking these cells, HIV is able to 
cause a progressive depletion of these cells at the various mucosal effector sites where they are found 
(Grossman et al., 2006; Kawamura et al., 2005); effectively resulting in the decreased ability of the 
immune system to react to life-threatening opportunistic infections due to cellular immunity being lost 
(Okoye and Picker, 2013). 
 
1.2.2.1. Mechanisms of Transmission 
Research has shown an array of theories with regard to the actual mechanism by which HIV enters a 
host. Broadly, they are divided into two main ideas being CD4-CCR5 dependent HIV transmission  
(Puigdomenech et al., 2008; Trkola et al., 1996) and CD4-CCR5 independent HIV transmission (Arias 
et al., 2003b; Boily-Larouche et al., 2012; Bomsel, 1997; Vidricaire et al., 2007a). 
 
1.2.2.1.1. CD4-CCR5 dependent HIV transmission 
The orthodox method of HIV transmission in the cell free virus form has been extensively researched. 
Scientists have determined that the  primary binding site for the HIV-1 virus is the CD4+ molecules 
located on certain white blood cells and is mediated by the viral surface glycoprotein gp120 (Trkola et 
al., 1996). Subsequent studies looked at a chemokine receptor (CCR5) and its influence on HIV 
transmission and viral efficacy (Trkola et al., 1996). Trkola et al demonstrated that the gp120/CD4+ 
interaction, although the primary contact, can be substituted by a gp120/CCR-5 interaction; and if both 
these synapses occur concomitantly, viral efficacy is greatly enhanced (Choe et al., 1996; Trkola et al., 
1996). To further support this theory, comparative studies looking at the effect of blocking the biological 
activity between various leukocyte function-associated antigens (LFA’s) and their intracellular 
adhesion molecule (ICAM) counterparts yielded supporting evidence which excluded such interactions 
as stand-alone mechanisms of HIV transmission; but rather agents relating to the enhanced transfer of 
HIV (Trkola et al., 1996). To a lower extent, studies have also looked at other receptors such as C-X-C 
chemokine receptor 4 (CXCR4) and various CC chemokine ligands (CCL) which have been implicated 
yet no firm conclusion can be made about their exact effect on HIV transmission (Abbas and Herbein, 
2014; Kalinina et al., 2013). 
 
1.2.2.1.2.. CD4-CCR5 independent HIV transmission 
The above mentioned orthodox mechanism is the most common known method of HIV infection, but 
there also exists an immune cell mediated mode of entry that may be relevant when leukocytes laden 
with HIV infect the trophoblast or facilitates passage of HIV through the barrier (Arias et al., 2003b).   
Therefore, if such integral contact between infected maternal leukocytes facilitates infection or 
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transcytosis of HIV, any signalling molecule that recruits and helps attach white cells to the 
syncytiotrophoblast will be an important factor in transmission. 
 
Another mechanism of HIV transmission across the placental barrier is through endocytosis of the HIV-
1 (Parry et al., 2006; Vidricaire et al., 2007a). Although studies have shown that HIV transmission is 
assisted by placental damage (for example inflammation (Soilleux and Coleman, 2003) or rupture of 
the fetal membranes (Burton et al., 1996)), the mechanism for HIV transmission in mothers without 
obstetric complications (for example co-infections with STDs, etc) is poorly understood (Arias et al., 
2003a; Parry et al., 2006). 
 
1.2.3. Transmission of HIV 
Frequency of transmission is determined by the amount of infectious virus in the body fluid of an 
infected individual and the amount of contact an individual has with the body fluid of the infected 
individual (Levy, 2007). The means of transmission from one individual to another are via sexual 
contact,  exposure to contaminated blood and mother to child transmission (Levy, 2007; Strauss and 
Strauss, 2002).  
 
1.2.3.1. Mother to Child Transmission of HIV 
Mother to Child Transmission (MTCT) of HIV, with just under a quarter of a million babies born with 
HIV annually (Chaib, 2015), is the most common way a child can get infected. HIV is known to be 
transmitted both during pregnancy, during parturition and post natally during breastfeeding (Mognetti 
et al., 2000). Significant reduction in transmission rates have been realized though antiretroviral 
therapy, access to healthcare and changes in breastfeeding advice, but in low and middle income 
countries access to healthcare is poor, resulting in higher than global transmission rates. In resource 
poor settings, it is near impossible to achieve sustainable transmission targets  (Chaib, 2015; Stats SA, 
2013). 
 
In treatment naïve mothers, the overall rate of transmission of HIV to their child is 15-45% compared 
to the reduced risk of below 5% for those mothers who are on a form of effective intervention to prevent 
MTCT (PMTCT) of HIV (WHO, 2014). The number of women able to access antiretroviral (ARV) 
treatment, in an effort to slow the progression of HIV into AIDS, has steadily increased over the years 
(Barron et al., 2013) but poor healthcare facilities, social stigma as well as a lack of HIV testing still 





Breastfeeding is one of the most intimate and natural interactions between a mother and her newborn 
child and although the best form of nutrition for the child, it is also a mechanism of HIV transmission 
from mother to child (Kourtis and Bulterys, 2010; Read and American Academy of Pediatrics 
Committee on Pediatric AIDS, 2003). Mothers who are not on any form of PMTCT, HIV transmission 
to their child is almost 40%. For those mothers on PMTCT, that risk is reduced to less than 5%. 
 
In terms of HIV-positive mothers in low- and middle-income countries, such as South Africa, the 
guidelines in the latest report from the World Health Organization has advised exclusive breastfeeding; 
especially where there is little access to health services, proper sanitation or clean drinking water (Bland 
et al., 2008; WHO, 2014). It has been recommended that HIV-positive mothers exclusively breastfeed 
for the first 6 months followed by weaning for a duration of one month (Kuhn et al., 2008). Any 
disruption in this system such as the ingestion of tea, water or other forms of nutrition increases the risk 
of HIV transmission via breastfeeding (Bland et al., 2008). 
 
Although access to ARV’s have increased, there is still a significant backlog with regards to ARV’s for 
children. Issues around breast health and providing adequate milk for their infants result in mothers 
disregarding exclusive breastfeeding, thereby increasing the risk of exposure and transmission of HIV 
to the infant (Buskens et al., 2007; Engebretsen et al., 2007). 
 
1.2.3.3. In-utero transmission 
The placenta functions as a selective filter. However it is not impervious to viruses (Al-husaini, 2009).    
The main method of infection of the unborn child may occur  via the placenta and directly into the 
embryo’s bloodstream (Arias et al., 2003a; Mognetti et al., 2000; Soilleux and Coleman, 2003; 
Vidricaire et al., 2007b).. Studies have shown that the fetus can acquire the HIV infection in the early 
stages of pregnancy as well as at term.  This in utero transmission may be caused by direct infection of 
the trophoblast barrier (Mognetti et al., 2000). Studies have therefore looked at the susceptibility of the 
trophoblast cells to infection by the HIV-1 virus and also the mechanism of viral infection (Al-husaini, 
2009; Arias et al., 2003a; Bomsel, 1997; Derrien et al., 2005; Lagaye et al., 2001b; Vidricaire et al., 
2007b, 2004). 
 
1.2.4. The Placenta and Its Structure  
The chorioallantoic placenta (Soares and Hunt, 2006) is responsible for the redirecting of the immune, 
endocrine and metabolic functions in favour of the developing embryo (Cross et al., 1994). At term, the 
human placenta has a disc-like appearance with an average weight of 470g (Kaufmann, 2006). 
Placentation begins as soon as the fetal membranes of the blastocyst make a close and stable contact 
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with the uterine mucosa. The placenta is the combination of embryonic and maternal tissues which work 
together to supply the much-needed nutrients to the growing fetus. The embryonic contribution towards 
the formation of the placenta is the result of the splitting of the membranous sac; resulting in two 
separate surfaces: the chorionic plate and the basal plate (Kaufmann, 2006).  
 
Placental villi originating from the chorionic plate are complex tree-like structures which protrude into 
the intervillous space found between the above mentioned surfaces (Wang and Zhao, 2010). The surface 
of the villi is known as the trophoblast layer and is in direct contact with the maternal blood supply. 
This trophoblastic layer is composed of two different layers of cells; the syncytiotrophoblast layer and 
the cytotrophoblast layer. The cytotrophoblast layer are the proliferating stem cells which give rise to 
the syncytiotrophoblast, which together with the fetal capillary basement membrane, which runs close 
to the maternal blood in the intervillous space, form the maternofetal transport barrier (Kaufmann, 2006; 
Wang and Zhao, 2010).  
 
There are three main types of villi found within a term placenta: stem, intermediate and terminal villi 
(Wang and Zhao, 2010). Stem villi or conducting villi are the largest villi and are characterized as 
having multiple arteries and veins, accompanied by easily identifiable muscular walls. Intermediate villi 
on the other hand differ from stem villi in that they appear without fetal vessels or stromal fibrosis. 
Terminal villi have been described to have a grape-like structure and are the side branches of the 
intermediate villi. Intermediate villi and terminal villi are mainly involved in exchange between the 
fetal and maternal circulation due to their slender capillaries and dilated sinusoids respectively 
(Kaufmann, 2006). 
 
Within the placental villi lie the fetal vessels including a mixture of fixed tissue cells, macrophages and 
connective tissue fibres (Kaufmann, 2006). These fetal vessels are connected to the fetal blood 
circulation via the chorionic plate and the umbilical cord (Kaufmann P, 2006). Although the maternal 
and fetal circulations do run very close, the formation of this maternofetal barrier ensures that the two 
blood systems never mix (Wang and Zhao, 2010). 
 
1.2.4.1. Function of the Placenta 
The main role of the placenta is to supply the growing fetus with adequate nutrition.  Passage of oxygen 
and glucose from the maternal to the  fetal circulation and contraflow of CO2 and waste products (Gude 
et al., 2004) occurs across  the  trophoblast layer. In this way, the placenta is the equivalent to a filter 
whereby harmful substances are kept away from the fetus, with only beneficial substances passing 
through to the fetus (Garnica and Chan, 1996; Kaufmann, 2006; Wang and Zhao, 2010). 
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Figure 1.2. Diagram depicting the function of the placenta during gestation. 
(http://www.ibmm.unibe.ch/unibe/medizin/ntbiomol/content/e537/e666/e155
4/e1555/e1564/e1566/PLACENTAbig_eng.jpg). 
The placenta is responsible for the production of a variety of hormones; for example oestrogen and 
progesterone. These hormones are very important in pregnancy as they prevent premature uterine 
contractions (Gilbert, 2014) and prime tissue within the uterus in preparation for the birthing process.  
 
The immunological role of the placenta is yet to be fully understood. IgG antibodies which are involved 
in the protection against infection are able to freely traverse the fetomaternal barrier in order to offer 
temporary protection to the fetus in utero (Simister and Story, 1997). This is a passive immunity offered 
from the mother which is an exact replica of the mother’s long term humoral immunity. IgM however, 
which is involved in the initial response against an exposure to a pathogen, is unable to traverse the 
placenta resulting in certain infectious diseases being able to be transmitted from mother to child (Gude 















1.2.5. Natural Immune Response 
The development of the immune system is said to be the result of evolutionary pressure of pathogens 
on a biological system (Kasahara, 2011; Male, 1992). Amongst the many important activities our 
immune system is responsible for, the main purpose of our immune system is to be able to identify the 
presence of a pathogen or infectious agent. Subsequent to this, activation of various mechanisms needed 
to protect an individual against such pathogens is necessary. In essence, an immune response essentially 
relies on the ability of the immune system to recognise an antigen on a pathogen as a foreign molecule 
and subsequently mount the appropriate immune response in order to eliminate the source of the antigen 
(Male, 1992). One of the main activities whereby the immune system is able to carry out its function is 
known as the recognition phase (Janeway and Medzhitov, 2002).  
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Recognition of a pathogen by immune cells such as lymphocytes is important but more importantly, 
immune cells need to have the ability to recognise what is known as “self” molecules. These self-
molecules are found on the cells of the individual and these epitopes should not normally be able to 
mount any sort of immune response.  
 
Immune responses which require lymphocyte recognition of a pathogen are generally referred to as 
adaptive immune responses (Guidotti and Chisari, 2001; Hsu and Nanan, 2014). Specificity and 
memory are central to this specific cell immunity as these actions are a second, enhanced reaction 
compared to the immune response upon the first exposure to said pathogen. First exposure immune 
reactions in response to a pathogen are normally carried out by the innate immune response (Janeway 
and Medzhitov, 2002). This immune response is less specific and merely mounts an immune response 
to any molecule which it identifies as being foreign (Janeway and Medzhitov, 2002).  
 
1.2.5.1. Antigen Presenting Cells 
In order for lymphocytes to initiate an immune response against an antigen, recognition must first take 
place (Janeway and Medzhitov, 2002). The role of APC’s is to present an antigen to the lymphocyte is 
in a recognizable form. When discussing an antigen presenting cell, we are referring to those subset of 
cells which are capable of MHC Class II antigen presentation. There are multiple cells which fall into 
this category of APC’s, including macrophages, dendritic cells and Langerhans cells (Alberts et al., 
2002; Liu, 2001); which will be discussed in more detail further on. It is important to note that although 
not all cells are able to perform Class II antigenic presentation, cells can be induced to express these 
molecules. For example, interferon-γ (IFN-γ) is said to be a very strong inducer of MHC Class II 
molecules on most cell types (Male, 1992). 
 
There are many factors which determine the ability of a cell to be an APC. Most importantly is its ability 
to internalize antigen and subsequently express the antigenic determinant on its cell surface in 
association with an MHC Class II molecule (Alberts et al., 2002). It is also important to note the role 
that cytokines play in combined antigen presentation (Janeway and Medzhitov, 2002). Antigen 
presentation and the subsequent control of the impending immune response is dependent on the 
aforementioned attributes. 
 
1.2.5.1.2. Macrophages and the Placenta 
In 1908, Elie Metchnikoff was awarded the Nobel Prize on his work regarding phagocytosis and its 
importance in assisting host defence against infection and injury (Gordon, 2007). In over a century  of 
research into these versatile cells, we have learnt about their distribution within a host, their 
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heterogeneous phenotypes and multiple complex functions involved in  tissue homeostasis in innate as 
well as adaptive immunity (Gordon, 2007). 
 
Originating in the bone marrow, from hematopoietic stem cells, macrophages are scavenger molecules 
that appear in a star-like formation (Gordon, 2007). They then travel through the body’s blood 
circulation and take up residence in certain tissues where they co-ordinate development, host defence 
by cytokine and chemokine secretion and phagocytosis (Gordon, 2007). They move in an amoeboid 
fashion, engulfing a variety of substances including cellular debris, microbes and foreign substances 
(Nagamatsu and Schust, 2010). Macrophages are said to be the link between the innate and the adaptive 
immune system through their functions; namely phagocytosis, digestion and antigen presentation to T-
lymphocytes (Abrahams et al., 2004; Gordon, 2007). The great plasticity of macrophages enables them 
to transform between various phenotypes in an effort to respond to activation agents which they 
encounter in their micro-environments and based on their expression profiles, macrophages can be 
classified into two broad groups; namely pro-inflammatory (M1) and anti-inflammatory (M2) 
macrophages (Olefsky and Glass, 2010; Sica and Mantovani, 2012).   
 
M2 macrophages are said to display immunosuppressive effects and resolve inflammation through the 
production of anti-inflammatory cytokines and various other molecules as well as being involved in the 
stimulation of the Th2 immune response (Gordon, 2007). In pregnancy, those macrophages which are 
found on the fetal side originate from the yolk sac and are known as Hofbauer cells found within 
chorionic villi while macrophages from the maternal side originate from the aforementioned 
hematopoietic stem cells and circulate in the blood prior to entering the endometrial decidual stroma 
and undergoing further differentiation into tissue macrophages  (decidual macrophages) (Abrahams et 
al., 2004; Nagamatsu and Schust, 2010). 
 
CD68 is a transmembrane protein which is expressed by human monocytes and tissue macrophages 
(NCIB, 2015). This protein has been localized to lysosomes and endosomes with a smaller division 
circulating to the surface of the cell. This Type 1 integral protein binds to tissue and organ specific 
lectins or selectins via its heavily glycosylated extracellular domain. As a member of the scavenger 
receptor family, it is involved in clearing cellular debris, recruiting and the subsequent activation of 
macrophages as well as the promotion of phagocytosis (NCIB, 2015). 
 
1.2.5.1.3. Dendritic Cells and the Placenta 
Similar to macrophages, dendritic cells (DC’s) are also derived from hematopoietic bone marrow 
progenitor cells (Liu, 2001) and are antigen presenting cells of the human immune system. Their main 
role as messengers between the adaptive and innate immune systems is based on the successful 
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processing of antigenic material and the subsequent presentation of this material at the cell surface to T 
cells (Banchereau et al., 2000; Geijtenbeek et al., 2000).  
 
Dendritic cells are found in tissue which is exposed to the external environment; for example the skin, 
nose and vagina. These dendritic cells have also been found in an immature state in blood where they 
migrate to the lymph nodes (de Witte et al., 2008) following activation by an antigen. Immature 
dendritic cells have high endocytic capabilities and a low rate of T-cell activation which aids in the 
constant sampling of the nearby environment for pathogens present (Banchereau et al., 2000; Steinman, 
2015). This sampling is further aided by structures known as dendrites, which are branched projections 
present during certain stages of dendritic cell development and also the namesake of these antigen 
presenting cells. Also present are branched projections called pattern recognition receptors (PRR’s), 
which are involved in the identification of a pathogen. The development of different subsets of dendritic 
cells has resulted in a variation in expression of pattern recognition surface receptors from subset to 
subset (Banchereau et al., 2000; Liu, 2001).  
 
These transmembrane protein receptors play a crucial role in the innate immune system as it recognises 
numerous evolutionary divergent pathogens, including multiple parasites as well as a range of viruses 
which impact on public health. In terms of HIV infection, dendritic cell-specific intercellular adhesion 
molecule-3-grabbing non-integrin (DC-SIGN), also known as CD209, has been identified as the protein 
receptor used to bind to dendritic cells. Diseases such as Dengue fever have also been related with DC-
SIGN and the proposed mechanism by which the dendritic cell initiates the primary immune response 
is the same (Tassaneetrithep et al., 2003). It is believed that dendritic cells endocytose the pathogens 
and transport them into the cell via a lysosomal compartments for degradation (Pantophlet, 2014). This 
is then followed by the receptor recycling to the surface of the dendritic cell (Steinman, 2015) and by 
the simultaneous use of MHC Class II molecule, presents the antigenic determinant to T cells thereby 
initiating an adaptive immune response (Pantophlet, 2014). 
 
However, conflicting reports say that it is possible that the bound HIV within the cell is protected in 
lysosomal compartments and evades degradation (Geijtenbeek et al., 2000). In this way, the infectious 
particle which is housed within these aforementioned compartments lie close to the surface of the cell 
membrane and thus increasing the propensity of HIV spread during the migration of the dendritic cells 
from the periphery to the lymphoid organs (Geijtenbeek et al., 2000). 
 
In vitro studies have looked at DC-SIGN as a receptor for HIV-1 and the role it plays in its transmission. 
Studies have shown that HIV-1 may enter either in a trans (without dendritic cell infection) or cis 
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(dendritic cell infection) followed by presentation to T cells to induce a robust infection (Ahmed et al., 
2015; Lee et al., 2001; Puryear and Gummuluru, 2012). 
 
1.2.5.1.4. Langerhans Cells and the Placenta 
Langerhans cells, specifically the epidermal Langerhans cells (LC), have been classified as dendritic 
cells (Romani et al., 2010) while others have classified Langerhans cells as macrophages (Thorbecke 
et al., 1980). A distinguishing feature of Langerhans Cells is their expression of CD1, a human 
thymocyte antigen, which sets this specific subset apart from other dendritic cells (Sutton et al., 1986).  
CD1a belongs to the family of transmembrane glycoproteins and are structurally related to the MHC 
proteins and are said to form heterodimers with beta-2-microglobulin, which forms part of the HLA 
complex and is important in cell-surface structure (Bernier, 1980). 
 
CD1a proteins are said to mediate the presentation of primary lipid and glycolipid antigens of self or 
those of microbial origin to circulating T cells (Mizumoto and Takashima, 2004; Salamero et al., 2001). 
The protein localizes to the plasma membrane as well as early recycling vesicles which are part of the 
early endocytic system (Salamero et al., 2001). Studies have looked at the role of Langerhans cells 
found in the vaginal mucosa (de Witte et al., 2008, 2007) as well as vaginal epithelium (Kawamura et 
al., 2005). The epithelial layer in which Langerhans cells have been shown to be present show a positive 
expression of cytokeratin. Cytokeratin belongs to the intermediate filament (IF) protein family (Barak 
et al., 2004) and is found in the intracytoplasmic cytoskeleton present in epithelial cells. Cytokeratin is 
also documented as being a reliable, strong and consistent marker for trophoblast cells throughout 
pregnancy (Daya and Sabet, 1991). If one had to consider the syncytiotrophoblast layer being analogous 
to an epithelial layer, it is plausible that Langerhans cells may be present below the syncytiotrophoblast 
layer in the placenta. 
 
Studies have looked at their presence in placental tissue yet their results have been inconclusive (Sutton 
et al., 1986). Due to the functioning of these cells and their cell-to-cell communication abilities 
(Kawamura et al., 2005), Langerhans cells are said to be the initial cellular targets in sexual transmission 
of HIV (Kawamura et al., 2005). Langerhans cells if present within the placenta may be cellular targets 
for HIV transmission. 
 
1.2.6. Normal Pregnancy 
Pregnancy has been said to be an immunological battle between the mother and the growing semi-
allogeneic fetus within her (Veenstra van Nieuwenhoven, 2003). Cells which are genetically distinct 
from that of the mother are automatically seen as foreign and are killed by the mother’s immune system 
(Veenstra van Nieuwenhoven, 2003). It is therefore imperative that differentiation of self and non-self 
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molecules is carried out by an individual’s immune system. Recognition of “self” is made possible by 
the presence of histocompatible human leukocyte antigens (HLA’s), specifically HLA-A and HLA-B. 
These membrane bound proteins are ‘read’ by lymphocytes and if found to be different, damaged or 
non-existent; the lymphocytes proliferate and kill the abnormal cells (Veenstra van Nieuwenhoven, 
2003). 
 
The trophoblastic layer found within the placenta is semi-allogeneic and may be treated as foreign by 
maternal immune cells. HLA-A and HLA-B proteins in the trophoblast layer are downregulated 
resulting in no immune response being mounted against the fetus. Rather than express HLA-A and 
HLA-B, the trophoblastic layer of the placenta produces a membrane protein called HLA-G. HLA-G is 
immunologically comparable to HLA-A and HLA-B and is therefore able to fool the maternal natural 
killer cells into believing that the trophoblastic cells are not foreign (Lash et al., 2010). In essence, the 
downregulation of HLA-A and HLA-B coupled with the production of HLA-G offers protection against 
the mother’s immune system as well as prevents the maternal natural killer cells from attacking the 
fetus (Veenstra van Nieuwenhoven, 2003).  
 
The placenta produces the female hormone progesterone. Studies have shown that progesterone inhibits 
lymphocyte proliferation and in this way if there is an immune response which is mounted against the 
fetus, due to the diminished number of lymphocytes, the immune response cannot be maintained (Lee 
et al., 2012). 
 
 1.2.7. Placenta and HIV Transmission 
The conundrum of HIV transmission from mother to child via the placenta is highly debated with 
multiple theories purported. However, the presence of HIV within the placenta is substantially 
supported by various studies carried out (Bhoopat et al., 2005; Lairmore et al., 1993; Martin et al., 1992; 
Vidricaire et al., 2007a).The mechanisms by which HIV traverses the fetal-maternal barrier is yet to be 
fully understood.  
 
Various studies suggest that the various receptors used by the virus in either the classical transmission 
pathway or the CD4-CCR5 independent pathways are present on the apical trophoblastic surface 
subjected to the infected mother’s blood.  However, there have been studies which dispute the presence 
of the orthodox CD4 and CCR5 receptors needed by HIV for transmission. Furthermore, studies have 
shown that differentiation of the cytotrophoblast to syncytiotrophoblast cells causes a decrease in the 
expression of receptors found on the trophoblast surface (Koi et al., 2001). This further strengthens the 




When the phenotype of the placenta and the infectious activity of HIV are considered, infection of the 
trophoblast layer or the transcytosis of the virus across the trophoblastic barrier becomes a possibility. 
Studies to support these theories look at the cell-to-cell interaction (Arias et al., 2003b; Burleigh et al., 
2006; Lagaye et al., 2001b) as a form of transcytosis of the virus across the trophoblastic layer (Bomsel, 
1997) while other studies have suggested that instead of merely transporting the virus across the barrier 
to the fetus, the trophoblastic cells are able to be infected (Geijtenbeek et al., 2000).  
 
The association of various immune cells in HIV transmission is an important key in understanding in 
utero transmission. Their significance in transmission has not been clearly identified and because of 
this, they continue to be an enigma. By evaluating the expression of cellular receptors specific for 
placental macrophages, dendritic cells and Langerhans cells which are used for HIV transmission, and 
comparing their expression in HIV positive and HIV negative patients; we hope to correlate such 
expression with both orthodox and unorthodox mechanisms of HIV transmission and their mediating 
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The markers for macrophage, dendritic and Langerhans cells typed the presence or absence of the 
immune cells in the placental tissue of HIV positive and HIV negative pregnancies, which when 
combined with their active role in the immune response during pregnancy has resulted in these cells 



























Objectives: Mother to child transmission of HIV remains high despite the use of antiretroviral therapy 
during pregnancy. The mechanism of HIV transmission across the placenta needs to be evaluated. This 
study aims to evaluate expression of key molecules implicated in HIV transmission within the placental 
exchange villi. 
 
Study Design: Immunohistochemical staining of placental tissue from normotensive placentae with 
target antibodies (CD68, DC-SIGN and CD1a) were analysed using light microscopy followed by 
morphometric and statistical analysis.  
 
Results: No significant difference was noted in the expression levels of DC-SIGN and CD68 between 
the groups. DC-SIGN expression was noted on immune cells as well as the syncytiotrophoblast of 
placental villi. CD68 expression on immune cells showed no difference between HIV positive and HIV 
negative groups. CD1a expression was not seen in the placental villi or immune cells in either group. 
 
Conclusion: Markers indicating the presence of Langerhans cells were not present in placental tissue. 
HIV infection does not alter the number of cells and quantity of expression of CD68 and DC-SIGN in 
normotensive pregnant women. Such expression provides evidence that HIV could use cell-mediated 
pathways to enter the circulation of the fetus, or at least infect the fetomaternal barrier. Further studies 



















According to the World Health Organization, over 800 women die per day due to pregnancy related 
complications (WHO et al., 2015). Maternal mortality, defined as death due to complications from 
pregnancy or childbirth (Tenth Interim Report on Confidential Enquiries into Maternal Deaths in South 
Africa, 2011), remains a global concern and has seen a dramatic rise in the last two decades due to non-
pregnancy related infections (NPRI’s), with 35% of the statistic attributed to HIV infected mothers 
(Saving Mothers 2011- 2013: Sixth Report on the Confidential Enquiries into Maternal Deaths in South 
Africa, 2015).  
 
Of equal concern is Mother to Child Transmission (MTCT) of HIV which occurs either during 
pregnancy, during parturition or postnatally during breastfeeding (Mognetti et al., 2000). MTCT has 
resulted in just under a quarter of a million babies born with HIV annually (Chaib, 2015). Significant 
reduction in transmission rates have been realized though antiretroviral therapy (ART), access to 
healthcare and changes in breastfeeding advice; but in low and middle income countries access to 
healthcare is poor, resulting in higher than global transmission rates. In these resource poor settings, it 
is near impossible to achieve sustainable transmission targets  (Chaib, 2015; Stats SA, 2013). 
 
The main method of infection of the unborn child may occur via the placenta (Arias et al., 2003a; 
Mognetti et al., 2000; Soilleux and Coleman, 2003; Vidricaire et al., 2007b) and this may occur early 
or late in pregnancy (Kourtis and Bulterys, 2010; Vidricaire et al., 2004). Such in utero transmission 
may be caused by direct infection of the trophoblast barrier (Mognetti et al., 2000). Several studies  
report that trophoblast cells are susceptible to HIV infection and attempt to elucidate the mechanism 
whereby this occurs (Al-husaini, 2009; Arias et al., 2003a; Bomsel, 1997; Derrien et al., 2005; Lagaye 
et al., 2001b; Vidricaire et al., 2007b, 2004). However, the exact mechanism which HIV utilizes is still 
unclear. HIV may use a non-receptor mediated pathway to traverse protective barriers such as the 
placenta in order to spread infection (Arias et al., 2003b; Lagaye et al., 2001a; Mognetti et al., 2000). 
 
The use of these pathways are facilitated by many important immunocompetent cells. These cells are 
also intricately linked to pregnancy. Successful pregnancy is dependent on a maternal tolerance of the 
semiallogeneic fetus (Svensson-Arvelund et al., 2015). At the fetomaternal interface the balance 
between the Th1/Th2 maternal immune response to a foreign body ensures the cell mediated activation 
of protective processes and recruitment of important immunocompetent cells such as decidual natural 
killer cells as well as macrophages. HIV present at the maternal fetal interface capitalises on this process 
by infecting responding cells or killing them, thus increasing the iterative infection of immune cells in 








Macrophages play key roles in all stages of pregnancy: implantation, placentation and parturition (Kim 
et al., 2007). Derived from blood monocytes, macrophages are central to successful placentation (Kim 
et al., 2007) while decidual macrophages found at the fetomaternal interface are needed for maternal 
tolerance of fetal antigens (Kim et al., 2007). During the gestational period, macrophages are also 
involved in surface presentation of molecules involved in both the innate and adaptive immune 
response. One such molecule is Dendritic Cell-Specific Intracellular adhesion molecules-3 (ICAM-3)-
grabbing Non-integrin (DC-SIGN) (Pillay et al., 2014). This C-type mannose-binding lectin is said to 
initiate the interaction between dendritic cells and resting T-cells (Pillay et al., 2014).  
 
DC-SIGN is highly expressed on dendritic cells and decidual macrophages as well as Hofbauer cells 
(Pillay et al., 2014). It has been proposed that in order for HIV to cause infection, it adheres to the 
Hofbauer cells and can possibly infect these placental macrophages (Pillay et al., 2014). The expression 
of DC-SIGN has been seen in the cervix (Trifonova et al., 2014), uterus (Ochiel et al., 2010)  as well as 
the placenta (Geijtenbeek et al., 2001). 
 
Macrophages and dendritic cells, which  are targeted by HIV appear to arise from a common lineage 
(Sutton et al., 1986). Another important cell type that are initial targets in the sexual transmission of 
HIV are Langerhans cells owing to their specialisation in antigen presentation and their cell-to-cell 
communication ability (Kawamura et al., 2005). Some epidermal Langerhans cells have been classified 
as dendritic cells (Romani et al., 2010) while others have classified Langerhans cells as macrophages 
(Thorbecke et al., 1980).  
 
The association of Langerhans cells with the placenta is uncertain but given the similarity between the 
types of tissue in which they are found and the placenta, it may be possible that they are found here. 
Cytokeratin is a common marker for both epithelial cells and trophoblast cells (Barak et al., 2004; 
Kawamura et al., 2005).  This knowledge is suggestive that the presence of Langerhans Cells are not 
only restricted to the vaginal epithelium but they could possibly be expressed in the placenta. 
Langerhans cells if present within the placenta may be cellular targets for HIV transmission. 
 
By evaluating the presence and density of expression of proteins specific for placental macrophages 
and dendritic cells which are used by HIV for its transmission, we will be able to correlate such 
expression with alternative methods of HIV transmission. In this study, we aim to evaluate the 










2. Materials and Methods 
2.1. Patient Sampling 
Placental samples were obtained from 60 Black South African normotensive primigravid women over 
the age of 18 yrs from a hospital servicing a catchment of at least 16 clinics in the Durban South region 
of Kwa-Zulu Natal, South Africa. These patients were stratified into HIV positive (n = 30) and HIV 
negative groups (n = 30); with the HIV positive group being further stratified according to their CD4+ 
cell counts; namely CD4+ count below 200 (n = 9) and CD4+ count above 200 (n = 21). 
 
2.2. Sample preparation 
This study uses formalin fixed paraffin embedded placental tissue of full thickness sampled from the 
central area of the placenta avoiding major blood vessels, areas of visible necrosis and/or infection. 
 
2.3. Microtomy 
Serial sections with a thickness of 3-4µm were cut on a rotary microtome (Leica 819; Germany) and 
lifted onto coated glass slides (Xtra™ Adhesive, Leica; Germany) which were baked overnight at 60°C 
followed by rehydration of the sections in xylene, 100% and a descending series of alcohol. Thereafter 
slides were incubated in picric acid for 30minutes and then sequentially brought to water.   
 
2.4. Immunohistochemical staining procedure for CD 209, CD1a and CD68. 
Immunohistochemical staining was performed using the Envision FlexMini High pH kit (DAKO, 
Denmark) according to the manufacturer instructions. Briefly, antigen retrieval was performed using 
the Envision™ FLEX target retrieval solution in the PT link (DAKO, Denmark) for 20 minutes at 95°C.  
Blocking of endogenous peroxidase present in the tissue was carried out by incubating slides for 5 
minutes in enzyme blocking reagent (DAKO, Denmark).   
 
Tissue sections were then incubated with the mouse antihuman CD209 (1:25, BioLegend, Clone 
9E9A8), mouse antihuman CD68 (1:50, R&D Systems, Clone #298807) and mouse antihuman CD1a 
(1:10, DAKO, Clone 010) antibodies diluted in an antibody diluent DAKO REALTM (DAKO, 
Denmark). The reaction was visually detected within 10min with diamino-benzidine (DAB) as the 
chromogen.  Nuclei were counterstained with Mayer’s haematoxylin (5min).  Sections were 
subsequently rehydrated and mounted in dibutylphthalate xylene (DPX).   
 
During optimization studies of the primary antibodies, both negative and method controls were used 









2.5. Morphometric image analysis of antibody expression 
All immunostained sections were viewed on the Zeiss Axioscope A1 Photomicroscope. Automated 
image analysis at an initial magnification of 40x was used to quantify immunostaining on slides.  
Two images per sample were captured for CD209 and CD68 staining.  This was not possible with CD1a 
due to the complete absence of staining. 
 
2.6. Statistical Analysis 
All data was tabulated and analyzed using SPSS 23 (IBM, Armonk USA). 
Demographic data was analyzed using Students T-test and Mann-Whitney U tests based on tests for 
normality. All categorical variables were analysed using Fisher’s/χ2 tests. A p-value of <.05 was 
considered statistically significant. Statistical analysis of the expression of CD209 and CD68 was 
performed to compare expression between HIV positive and HIV negative patient groups. The 
percentage of brown stain obtained within the placental villi per field area was captured in two 
consecutive images. The percentage from each of the two images from each sample was averaged. This 
average percentage was converted to a percentage out of 100.The value obtained was the value used for 

























3.1. Demographic Statistics 
Demographic statistics are outlined in Table 1. There was no significant difference of baby weight 
between the different groups however there was a significant difference between placental weight     (p 
= 0.005), with HIV positive placentae having a greater weight (517.33±81.59) than HIV negative 
placentae (457.10±77.81). No histopathological differences were noted between placentae of the 
various groups. 
 
Table 1.1. Table showing demographic data of HIV Positive and HIV Negative normotensive groups. 
 
3.2. DC-SIGN expression in HIV positive and HIV negative normotensive placentae. 
DC-SIGN expression was immunohistochemically determined. Positive staining was noted on the 
syncytiotrophoblast layer of placental villi (Figure 1.1.) as well as immune cells (Figure 1.2.) in the 
fetal and maternal blood circulations in both HIV negative and HIV positive groups. 
Staining was noted in conducting villi (Figure 1.1.a, c and e) and exchange villi (Figure 1.1.b, d and f). 
Independent samples Mann-Whitney U test was performed to determine significance of expression 
between conducting and exchange villi. There was no significant difference in expression in the 
conducting villi or the exchange villi [p = 0.671]. There was also no significant difference in expression 
in the syncytiotrophoblast layer between the HIV negative (18.09±11.95) (Figure 1.1.a and b) and HIV 
positive groups (21.05±16.24) (Figure 1.1.c, d, e and f). There was no difference in expression of DC-
SIGN with CD4 counts above 200 (Figure 1.1.c and d) or CD4 counts below 200 (Figure 1.1.e and f). 
  Normotensive pregnant women   
  HIV negative  HIV positive  P value 
N 30 30   
Maternal age (years) 19.87±1.93 23.63±3.17 <.001* 




31.85±4.83 28.94±4.28 .016* 
Systolic pressure (mmHG) 121.36±13.19 119.87±9.47 .812 
Diastolic pressure (mmHG) 70.36±10.02 69.50±13.06 .762 
Gestational age at birth (weeks) 38.42±1.46 38.90±1.60 .225 
Baby weight (kg) 3.32±0.43 3.22±0.39 .344 







Immune cells which stained positive for the expression of DC-SIGN were found in the fetal as well as 
the maternal blood in both HIV negative normotensive placentae (Figure 1.2.a) as well as HIV positive 




































Figure 1.1. Immunostaining for DC-SIGN (indicated by the black arrows) of both HIV positive 
and negative placentae with (a),(c) and (e) showing conducting villi sections and (b), (d) and 
(f) depicting exchange villi sections. Both (a) and (b) show DC-SIGN positive 
immunoreactivity in normotensive HIV negative conducting villi (a) and HIV negative 
exchange villi (b).  Micrograph (c) depicts staining of conducting villi in an HIV positive 
sample with a CD4+ cell count greater than 200 while positive staining of the exchange villi 
can be seen in micrograph (d). In micrograph (e), we can see the presence of DC-SIGN in the 
conducting villi in the placenta while micrograph (f) demonstrates the similar result in 























3.3. CD68 expression in HIV positive and HIV negative normotensive placentae. 
Expression of CD68 was noted on circulating immune cells in both fetal and maternal blood circulations 
of the HIV negative group (Figure 1.3.a and b) as well as the HIV positive group (Figure 1.3.c, d, e and 
f) as well as Hofbauer cells in placental villi (Figure 1.3.b).   Independent Samples Whitney U test was 
performed to determine significance of expression between conducting and exchange villi. No 
significant difference was noted between the conducting villi or the exchange villi [p = .355]. There 
was also no significant difference in expression between HIV negative placenta (13.33±7.49) (Figure 
1.3.a and b) and HIV positive placenta (10.58±4.33) (Figure 1.3.c, d, e and f). Further statistical analysis 
was carried out on the expression found in the subgroups of the HIV positive placenta and no difference 
was noted between those placentae with a CD4+ count above 200 (Figure 1.3.c and d) and placentae 












Figure 1.2. Immunostaining for DC-SIGN on immune cells (indicated by the black arrows) of 
HIV negative and positive placentae with (a) showing HIV negative normotensive sections and 
(b) depicting HIV positive sections. Both (a) and (b) show immunoreactivity on immune cells 
in both the fetal as well as maternal circulation. Positive expression can also be noted on the 












































Figure 1.3. Immunostaining for CD68 of both HIV positive and negative placentae with (a), 
(c) and (e) showing expression on immune cells present in the maternal circulation and (b), (d) 
and (f) depicting positive expression of CD68 on immune cells present in placental villi tissue. 
Both (a) and (b) show CD68 positive immunoreactivity in normotensive HIV negative maternal 
circulation (a) and HIV negative placental villi (b).  Micrograph (c) depicts staining of immune 
cells in the maternal as well as fetal circulation in an HIV positive sample with a CD4+ cell 
count greater than 200 while positive staining of an immune cell within the placental villi can 
be seen in micrograph (d). In micrograph (e), we can see the presence of CD68 in both the 
maternal and fetal circulation within the placenta while micrograph (f) demonstrates the similar 
result in the fetal circulation within placental tissue from patients with a CD4+ count less than 









3.4. CD1a expression in HIV positive and HIV negative Normotensive placentae. 
Optimization of the CD1a antibody utilized skin tissue where Figure 1.4a depicts the negative control 
and Figure 1.4.b depicts the positive control, where expression can be seen on the Langerhans cells 
found embedded in the upper layers of skin. Immunohistochemistry of CD1a was carried out on all 
samples. No expression of CD1a was noted on HIV positive samples (Figure 1.4.c and d) or HIV 
negative samples (Figure 1.4.e and f). Images were captured at a magnification of 40x (Figure 1.4.d and 
f) and 20x (Figure 1.4.c and e) which shows no CD1a expression in the placental tissue samples in the 

























































Figure 1.4. Immunostaining for CD1a of HIV positive and negative placentae with (a) showing 
the negative control using skin tissue and (b) showing the positive control using skin tissue. 
Micrograph (c) and (d) depicts HIV negative normotensive sections while (e) and (f) depict HIV 
positive sections. Micrograph (a) captured at 20x and micrograph (b) captured at 40x show no 
immunoreactivity in normotensive HIV negative conducting villi (c) and exchange villi (d).  
Similar results can be seen in micrograph (c) captured at 20x depicting no staining of stem villi 
as well as no immunoreactivity noted in exchange villi (d),  captured at 40x, within HIV positive 










The aim of this study was to localize proteins such as DC-SIGN, CD68 and CD1a which have been 
implicated in HIV transmission from mother to child. When comparing the results obtained from the 
HIV positive and HIV negative placentae, we found that the expression of DC-SIGN was the same in 
both HIV negative as well as HIV positive samples. A similar observation was seen for CD68. The 
Langerhans cells on which CD1a is expressed was not found in the HIV positive or the HIV negative 
placentae in this study. 
 
CD1a which is a specific marker of Langerhans cells is associated with the presentation of antigens to 
T cells (Mizumoto and Takashima, 2004). CD1a is important as it mediates antigen presentation by an 
HLA-independent pathway (Schulke et al., 2008). Studies have looked at cells similar to those on which 
CD1a are found and have reported a decline in their presence as the pregnancy progressed. As this study 
used term placenta, this could possibly explain the lack of CD1a positive cells (Qian et al., 2015). 
Further studies looking at pre-term placenta would be beneficial as it is possible that CD1a positive 
cells could be involved in the initial infection by HIV.  
 
In a normal pregnancy, of the number of immune cells found in the placental tissue, approximately 70% 
of them are natural killer cells, 20-25% are macrophages and 1.7% are dendritic cells (Mor, 2007). The 
importance of dendritic cells and macrophages in pregnancy has been shown through various studies 
where a decrease in dendritic cell populations have resulted in the lack of trophoblast invasion as well 
as decidual formation (Abrahams et al., 2004) and where macrophages play a pivotal role in the vascular 
remodelling within the uterine wall to ensure the appropriate utero-placental circulation (Nagamatsu 
and Schust, 2010), amongst other functions. 
 
In this study, we have seen that CD68 is present on immune cells in the maternal circulation (Figure 
1.3a, c and e) as well as immune cells found within the fetal circulation (Figure 1.3b, d and f). 
Specialized macrophages of the placenta known as Hofbauer cells have also been seen in HIV negative 
(Figure 1.3b) as well as HIV positive placental tissue. The lack of difference in the number of CD68 
positive cells in HIV infection and their involvement in HIV infection, suggests that these cells provide 
a reservoir for HIV infection, even where there are depleted T cell subsets in progressed disease. Unlike 
the orthodox CD4+ T cells which are the primary targets of HIV which decrease as the severity of the 
disease increases, macrophages are active from the initial placentation process and remain constant 








As important as macrophages are in various gestational processes, studies have shown that macrophages 
are able to be infected in vivo with HIV-1, resulting in both viral antigens as well as infectious virus in 
the culture supernatants (Kesson et al., 1993; McGann et al., 1994). Macrophages have been shown to 
express various C-type lectins on their cell surface which have the ability to recognize both foreign 
ligands originating from microbes as well as those originating from endogenous microbes. Once such 
lectin is the dendritic cell-specific intracellular adhesion molecule 3 grabbing non-integrin (DC-SIGN); 
which was first isolated and identified on immature dendritic cells (Nagamatsu and Schust, 2010). 
 
The exploitation of the dendritic cells, on which DC-SIGN was first isolated, by HIV is still unclear but 
it is said to increase efficiency of T cell infection (Geijtenbeek et al., 2001; Geijtenbeek et al., 2000; 
Pöhlmann et al., 2001). Studies have stated that DC-SIGN does not function as a receptor for the virus 
but rather promotes the efficient in trans infection of T cells which express CD4 and chemokine 
receptors by increasing concentration of virus at the dendritic cell surface (Geijtenbeek et al., 2000), 
while others have reported that the function of DC-SIGN is independent of the co-expression of CD4 
and the associated appropriate receptors (Geijtenbeek et al., 2001). This is supported by studies which 
have shown that the viral gp120 which is used by HIV to enter T cells has a higher affinity for DC-
SIGN compared to CD4 (Curtis et al., 1992; Geijtenbeek et al., 2000). This is further confirmed by 
studies which have shown that blockage of DC-SIGN has resulted in a slightly decreased transfer of 
HIV to T-cells and ultimately confirming the independent mechanisms of HIV transmission (Granelli-
Piperno et al., 2005). Together with this, DC-SIGN is able to capture HIV for more than four days 
which not only preserves its effectiveness but also provides the time needed to enter lymph node, as 
transport by dendritic cells only requires two days (Geijtenbeek et al., 2000). 
 
In the light of this, the importance of DC-SIGN cannot be overlooked. In this study, the expression of 
DC-SIGN was seen on immune cells in both the fetal and maternal circulation and in contrast to other 
studies (Pillay et al., 2014), also on the syncytiotrophoblast layer of both conducting as well as exchange 
placental villi.  
 
The evidence provided by various studies regarding DC-SIGN support the theory whereby infection of 
the placenta takes place prior to the infection of the fetus. Given the greater affinity of gp120 for the 
DC-SIGN membrane protein (Geijtenbeek et al., 2000), it is plausible to believe that as a result of a 
greater expression of DC-SIGN on placental villi, a greater concentration of virus and viral particles 






The implication of DC-SIGN and CD68 as possible mechanisms of HIV transmission is supported by 
the results which indicate a continual presence of cells presenting these proteins throughout gestation 
(Abrahams et al., 2004; Soilleux et al., 2001a). We have seen that the number of cells which express 
these markers remain unchanged regardless of HIV status. As studies have proven the ease in which 
these proteins can be exploited, in the absence of orthodox receptors where HIV transmission to the 
baby has been reported, it is important to assess these proteins to determine the manner in which they 
successfully perform their immunological role and how this immunological role can be altered by which 
transmission could possibly result.  In this study we have seen that the HIV status of a mother does not 
alter the number of cells and quantity of expression of CD68 and DC-SIGN in normotensive pregnant 
women. With DC-SIGN positive Hofbauer cells easily being able to travel from the mother via the 
umbilical vein to the fetus (Soilleux et al., 2001a), an increase in number of these cells expressing these 
proteins from placentation through to gestation is of great significance. Such expression provides 
evidence that HIV could use a cell-mediated pathway to enter the fetal circulation, or at least infect the 
fetomaternal barrier.  
 
As the participants of this study were on a form of ARV treatment, the effect of the treatment on the 
results obtained needed to be determined. Although ARV’s have greatly reduced HIV transmission, 
according to previous studies, it is possible that the implementation of ARV treatments such as HAART 
tend to direct HIV infection towards a cell-associated mechanism as there appears to be a higher 
efficiency of the vertical transmission of HIV in cases where viral loads remain low. If the function of 
DC-SIGN is minimal when the viral load is reported low, it is plausible to assume that their efficiency 
in promoting the vertical transmission of HIV is greatly increased. 
 
CD68 and DC-SIGN play a role in HIV transmission yet their connection to one another is unclear. It 
is possible that the mechanism by which HIV-1 infects trophoblast cells incorporates the conventional 
as well as the non-conventional receptors mediated route to ensure a successful infection. Confirmatory 
tests to isolate markers of HIV infection within these cells would provide valuable insight into their role 
in transmission and we propose this for further study. Identifying the association of these cells with 
placentae at varying stages of gestation and the immunological phenotype will elucidate their role not 










5. Conflict of Interest 




C. J. Vallen was awarded a bursary for the work described in this manuscript by The College of Health 
Sciences at the Nelson R. Mandela School of Medicine. 
 
7. Acknowledgements 
The authors gratefully acknowledge the technical assistance of D. Margolis from the Optics and 

























Abbas, W., Herbein, G., 2014. Plasma membrane signaling in HIV-1 infection. Biochim. Biophys. 
Acta BBA - Biomembr. 1838, 1132–1142. doi:10.1016/j.bbamem.2013.06.020. 
 
Abrahams, V.M., Kim, Y.M., Straszewski, S.L., Romero, R., Mor, G., 2004. Macrophages and 
apoptotic cell clearance during pregnancy. Am. J. Reprod. Immunol. N. Y. N 1989 51, 275–
282. doi:10.1111/j.1600-0897.2004.00156.x. 
 
Ahmed, Z., Kawamura, T., Shimada, S., Piguet, V., 2015. The Role of Human Dendritic Cells in 
HIV-1 Infection. J. Invest. Dermatol. 135, 1225–1233. doi:10.1038/jid.2014.490. 
 
Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., Walter, P., 2002. Chapter 24: T cells and 
MHC Proteins, in: Molecular Biology of the Cell. Garland Science, New York. 
 
Al-husaini, A.M., 2009. Role of placenta in the vertical transmission of human immunodeficiency 
virus. J. Perinatol. 29, 331–336. doi:10.1038/jp.2008.187. 
 
Arias, R.A., Muñoz, L.D. ía., Muñoz-Fernández, M.A., 2003a. Transmission of HIV-1 infection 
between trophoblast placental cells and T-cells take place via an LFA-1-mediated cell to cell 
contact. Virology 307, 266–277. doi:10.1016/S0042-6822(02)00040-5. 
 
Ashkar, A.A., Di Santo, J.P., Croy, B.A., 2000. Interferon gamma contributes to initiation of uterine 
vascular modification, decidual integrity, and uterine natural killer cell maturation during 
normal murine pregnancy. J. Exp. Med. 192, 259–270. 
 
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.-J., Pulendran, B., Palucka, K., 
2000. Immunobiology of Dendritic Cells. Annu. Rev. Immunol. 18, 767–811. 
doi:10.1146/annurev.immunol.18.1.767. 
 
Barak, V., Goike, H., Panaretakis, K.W., Einarsson, R., 2004. Clinical utility of cytokeratins as tumor 
markers. Clin. Biochem. 37, 529–540. doi:10.1016/j.clinbiochem.2004.05.009. 
 
Barron, P., Pillay, Y., Doherty, T., Sherman, G., Jackson, D., Bhardwaj, S., Robinson, P., Goga, A., 
2013. Eliminating mother-to-child HIV transmission in South Africa. Bull. World Health 
Organ. 91, 70–74. doi:10.2471/BLT.12.106807. 
 
Bernier, G.M., 1980. beta 2-Microglobulin: structure, function and significance. Vox Sang. 38, 323–
327. 
 
Bhoopat, L., Khunamornpong, S., Sirivatanapa, P., Rithaporn, T., Lerdsrimongkol, P., Thorner, P.S., 
Bhoopat, T., 2005. Chorioamnionitis is associated with placental transmission of human 







Bland, R.M., Little, K.E., Coovadia, H.M., Coutsoudis, A., Rollins, N.C., Newell, M.-L., 2008. 
Intervention to promote exclusive breast-feeding for the first 6 months of life in a high HIV 
prevalence area. AIDS Lond. Engl. 22, 883–891. doi:10.1097/QAD.0b013e3282f768de. 
 
Boily-Larouche, G., Milev, M.P., Zijenah, L.S., Labbé, A.-C., Zannou, D.M., Humphrey, J.H., Ward, 
B.J., Poudrier, J., Mouland, A.J., Cohen, É.A., Roger, M., 2012. Naturally-Occurring Genetic 
Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother-To-
Child Transmission. PLoS ONE 7, e40706. doi:10.1371/journal.pone.0040706. 
 
Bomsel, M., 1997. Transcytosis of infectious human immunodeficiency virus across a tight human 
epithelial cell line barrier. Nat. Med. 3, 42–47. doi:10.1038/nm0197-42. 
 
Burleigh, L., Lozach, P.-Y., Schiffer, C., Staropoli, I., Pezo, V., Porrot, F., Canque, B., Virelizier, J.-
L., Arenzana-Seisdedos, F., Amara, A., 2006. Infection of Dendritic Cells (DCs), Not DC-
SIGN-Mediated Internalization of Human Immunodeficiency Virus, Is Required for Long-
Term Transfer of Virus to T Cells. J. Virol. 80, 2949–2957. doi:10.1128/JVI.80.6.2949-
2957.2006. 
 
Burton, G.J., O’Shea, S., Rostron, T., Mullen, J.E., Aiyer, S., Skepper, J.N., Smith, R., Banatvala, J., 
1996. Physical breaks in the placental trophoblastic surface: significance in vertical 
transmission of HIV. AIDS Lond. Engl. 10, 1294–1296. 
 
Buskens, I., Jaffe, A., Mkhatshwa, H., 2007. Infant feeding practices: Realities and mind sets of 
mothers in southern Africa. AIDS Care 19, 1101–1109. doi:10.1080/09540120701336400. 
 
Chaib, F., 2015. WHO validates elimination of mother-to-child-transmission of HIV and Syphillis in 
Cuba. Geneva. 
 
Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P.D., Wu, L., Mackay, C.R., LaRosa, 
G., Newman, W., Gerard, N., Gerard, C., Sodroski, J., 1996. The β-Chemokine Receptors 
CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates. Cell 85, 1135–1148. 
doi:10.1016/S0092-8674(00)81313-6. 
 
Cross, J.C., Werb, Z., Fisher, S.J., 1994. Implantation and the placenta: key pieces of the development 
puzzle. Science 266, 1508–1518. 
 
Curtis, B.M., Scharnowske, S., Watson, A.J., 1992. Sequence and expression of a membrane-
associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency 
virus envelope glycoprotein gp120. Proc. Natl. Acad. Sci. U. S. A. 89, 8356–8360. 
 
David, F.J.E., Autran, B., Tran, H.C., Menu, E., Raphael, M., Debre, P., His, B.L., Wegman, T.G., 
Barre-Sinoussi, F., Chaouat, G., 1992. Human trophoblast cells express CD4 and are 
permissive for productive infection with HIV--1. Clin. Exp. Immunol. 88, 10–16. 
 
Daya, D., Sabet, L., 1991. The use of cytokeratin as a sensitive and reliable marker for trophoblastic 






Derrien, M., Faye, A., Dolcini, G., Chaouat, G., Barré-Sinoussi, F., Menu, E., 2005. Impact of the 
Placental Cytokine-Chemokine Balance on Regulation of Cell-Cell Contact-Induced Human 
Immunodeficiency Virus Type 1 Translocation across a Trophoblastic Barrier In Vitro. J. 
Virol. 79, 12304–12310. doi:10.1128/JVI.79.19.12304-12310.2005. 
 
de Witte, L., Nabatov, A., Geijtenbeek, T.B.H., 2008. Distinct roles for DC-SIGN+-dendritic cells and 
Langerhans cells in HIV-1 transmission. Trends Mol. Med. 14, 12–19. 
doi:10.1016/j.molmed.2007.11.001 
 
de Witte, L., Nabatov, A., Pion, M., Fluitsma, D., de Jong, M.A.W.P., de Gruijl, T., Piguet, V., van 
Kooyk, Y., Geijtenbeek, T.B.H., 2007. Langerin is a natural barrier to HIV-1 transmission by 
Langerhans cells. Nat. Med. 13, 367–371. doi:10.1038/nm1541. 
 
Dorenbaum, 2001. An international phase III trial of standard antiretroviral (ARV) prophylaxis plus 
nevirapine (NVP) for prevention of preinatal HIV transmission. Abstr. 8th Conf. Retroviruses 
Opportunistic Infect. 
 
Engebretsen, I., Wamani, H., Karamagi, C., Semiyaga, N., Tumwine, J., Tylleskär, T., 2007. Low 
adherence to exclusive breastfeeding in Eastern Uganda: A community-based cross-sectional 
study comparing dietary recall since birth with 24-hour recall. BMC Pediatr. 7, 10. 
doi:10.1186/1471-2431-7-10. 
 
Fassati, A., 2006. HIV Infection of non-dividing cells: A divisive problem. Retrovirology 74. 
doi:10.1186/1742-4690-3-74. 
 
Garnica, A.D., Chan, W.Y., 1996. The role of the placenta in fetal nutrition and growth. J. Am. Coll. 
Nutr. 15, 206–222. doi:10.1080/07315724.1996.10718591. 
 
Geijtenbeek, T.B.., Kwon, D.S., Torensma, R., van Vliet, S.J., van Duijnhoven, G.C.., Middel, J., 
Cornelissen, I.L.M.H.., Nottet, H.S.L.., KewalRamani, V.N., Littman, D.R., Figdor, C.G., van 
Kooyk, Y., 2000. DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances 
trans-Infection of T Cells. Cell 100, 587–597. doi:10.1016/S0092-8674(00)80694-7. 
 
Geijtenbeek, T.B., van Vliet, S.J., van Duijnhoven, G.C., Figdor, C.G., van Kooyk, Y., 2001. DC-
SIGN, a dentritic cell-specific HIV-1 receptor present in placenta that infects T cells in trans-a 
review. Placenta 22 Suppl A, S19–23. doi:10.1053/plac.2001.0674. 
 
Gilbert, S.F., 2014. Developmental biology, Tenth edition. ed. Sinauer Associates, Inc., Publishers, 
Sunderland, MA, USA.. 
 
Gordon, S., 2007. The macrophage: Past, present and future. Eur. J. Immunol. 37, S9–S17. 
doi:10.1002/eji.200737638. 
 
Granelli-Piperno, A., Pritsker, A., Pack, M., Shimeliovich, I., Arrighi, J.-F., Park, C.G., Trumpfheller, 
C., Piguet, V., Moran, T.M., Steinman, R.M., 2005. Dendritic Cell-Specific Intercellular 





Normal Human Lymph Node and Is Not Required for Dendritic Cell Stimulation of the 
Mixed Leukocyte Reaction. J. Immunol. 175, 4265–4273. doi:10.4049/jimmunol.175.7.4265. 
 
Grossman, Z., Meier-Schellersheim, M., Paul, W.E., Picker, L.J., 2006. Pathogenesis of HIV 
infection: what the virus spares is as important as what it destroys. Nat. Med. 12, 289–295. 
doi:10.1038/nm1380. 
 
Gude, N.M., Roberts, C.T., Kalionis, B., King, R.G., 2004. Growth and function of the normal human 
placenta. Thromb. Res. 114, 397–407. doi:10.1016/j.thromres.2004.06.038. 
 
Guidotti, L.G., Chisari, F.V., 2001. Noncytolytic Control of Viral Infections by the Innate and 
Adaptive Immune Response. Annu. Rev. Immunol. 19, 65–91. 
doi:10.1146/annurev.immunol.19.1.65. 
 
Hsu, P., Nanan, R.K.H., 2014. Innate and Adaptive Immune Interactions at the Fetal–Maternal 
Interface in Healthy Human Pregnancy and Pre-Eclampsia. Front. Immunol. 5, 125. 
doi:10.3389/fimmu.2014.00125. 
 
Iyidogan, P., Anderson, K., 2014. Current Perspectives on HIV-1 Antiretroviral Drug Resistance. 
Viruses 6, 4095–4139. doi:10.3390/v6104095. 
 
Janeway, C.A., Medzhitov, R., 2002. Immate Immune Recognition. Annu. Rev. Immunol. 20, 197–
216. doi:10.1146/annurev.immunol.20.083001.084359. 
 
Kalinina, O.V., Pfeifer, N., Lengauer, T., 2013. Modelling binding between CCR5 and CXCR4 
receptors and their ligands suggests the surface electrostatic potential of the co-receptor to be 
a key player in the HIV-1 tropism. Retrovirology 10, 130. doi:10.1186/1742-4690-10-130. 
 
Kasahara, M., 2011. Immune System: Evolutionary Pressure of Infectious Agents, in: John Wiley & 
Sons, Ltd (Ed.), eLS. John Wiley & Sons, Ltd, Chichester, UK. 
 
Kaufmann P, B.K., 2006. Pathology of the Human Placenta [Internet]. Springer, New York. 
 
Kawamura, T., Kurtz, S.E., Blauvelt, A., Shimada, S., 2005. The role of Langerhans cells in the 
sexual transmission of HIV. J. Dermatol. Sci. 40, 147–155. 
doi:10.1016/j.jdermsci.2005.08.009. 
 
Kesson, A.M., Fear, W.R., Kazazi, F., Mathijs, J.-M., Chang, J., King, N.J.C., Cunningham, A.L., 
1993. Human Immunodeficiency Virus Type 1 Infection of Human Placental Macrophages In 
Vitro. J. Infect. Dis. 168, 571–579. doi:10.1093/infdis/168.3.571. 
 
Kim, J.-S., Romero, R., Cushenberry, E., Kim, Y.M., Erez, O., Nien, J.K., Yoon, B.H., Espinoza, J., 
Kim, C.J., 2007. Distribution of CD14+ and CD68+ Macrophages in the Placental Bed and 







Koi, H., Zhang, J., Parry, S., 2001. The mechanisms of placental viral infection. Ann. N. Y. Acad. Sci. 
943, 148–156. 
 
Kourtis, A.P., Bulterys, M., 2010. Mother-to-child transmission of HIV: pathogenesis, mechanisms 
and pathways. Clin. Perinatol. 37, 721–737, vii. doi:10.1016/j.clp.2010.08.004. 
 
Kuhn, L., Aldrovandi, G.M., Sinkala, M., Kankasa, C., Semrau, K., Mwiya, M., Kasonde, P., Scott, 
N., Vwalika, C., Walter, J., Bulterys, M., Tsai, W.-Y., Thea, D.M., 2008. Effects of Early, 
Abrupt Weaning on HIV-free Survival of Children in Zambia. N. Engl. J. Med. 359, 130–141. 
doi:10.1056/NEJMoa073788. 
 
Lagaye, S., Derrien, M., Menu, E., Coïto, C., Tresoldi, E., Mauclère, P., Scarlatti, G., Chaouat, G., 
Barré-Sinoussi, F., Bomsel, M., European Network for the Study of In Utero Transmission of 
HIV-1, 2001a. Cell-to-cell contact results in a selective translocation of maternal human 
immunodeficiency virus type 1 quasispecies across a trophoblastic barrier by both 
transcytosis and infection. J. Virol. 75, 4780–4791. doi:10.1128/JVI.75.10.4780-4791.2001. 
 
Lairmore, M.D., Cuthbert, P.S., Utley, L.L., Morgan, C.J., Dezzutti, C.S., Anderson, C.L., Sedmak, 
D.D., 1993. Cellular localization of CD4 in the human placenta. Implications for maternal-to-
fetal transmission of HIV. J. Immunol. Baltim. Md 1950 151, 1673–1681. 
 
Lash, G.E., Robson, S.C., Bulmer, J.N., 2010. Review: Functional role of uterine natural killer (uNK) 
cells in human early pregnancy decidua. Placenta 31 Suppl, S87–92. 
doi:10.1016/j.placenta.2009.12.022. 
 
Lee, B., Leslie, G., Soilleux, E., O’Doherty, U., Baik, S., Levroney, E., Flummerfelt, K., Swiggard, 
W., Coleman, N., Malim, M., Doms, R.W., 2001. cis Expression of DC-SIGN allows for 
more efficient entry of human and simian immunodeficiency viruses via CD4 and a 
coreceptor. J. Virol. 75, 12028–12038. doi:10.1128/JVI.75.24.12028-12038.2001. 
 
Lee, J.H., Lydon, J.P., Kim, C.H., 2012. Progesterone suppresses the mTOR pathway and promotes 
generation of induced regulatory T cells with increased stability. Eur. J. Immunol. 42, 2683–
2696. doi:10.1002/eji.201142317 
 
Levy, J.A., 2007. HIV and the pathogenesis of AIDS, 3rd ed. ed. ASM Press, Washington, D.C. 
 
Liu, Y.-J., 2001. Dendritic Cell Subsets and Lineages, and Their Functions in Innate and Adaptive 
Immunity. Cell 106, 259–262. doi:10.1016/S0092-8674(01)00456-1. 
 
Male, D. (Ed.), 1992. Advanced immunology, 2. ed., reprinted. ed. Gower, London. 
 
Marlink, R., Kanki, P., Thior, I., Travers, K., Eisen, G., Siby, T., Traore, I., Hsieh, C., Dia, M., 
Gueye, E., et,  al., 1994. Reduced rate of disease development after HIV-2 infection as 






Martin, A.W., Brady, K., Smith, S.I., DeCoste, D., Page, D.V., Malpica, A., Wolf, B., Neiman, R.S., 
1992. Immunohistochemical localization of human immunodeficiency virus p24 antigen in 
placental tissue. Hum. Pathol. 23, 411–414. doi:10.1016/0046-8177(92)90088-K. 
 
McGann, K.A., Collman, R., Kolson, D.L., Gonzalez-Scarano, F., Coukos, G., Coutifaris, C., Strauss, 
J.F., Nathanson, N., 1994. Human immunodeficiency virus type 1 causes productive infection 
of macrophages in primary placental cell cultures. J. Infect. Dis. 169, 746–753. 
 
Mizumoto, N., Takashima, A., 2004. CD1a and langerin: acting as more than Langerhans cell 
markers. J. Clin. Invest. 113, 658–660. doi:10.1172/JCI200421140. 
 
Mognetti, B., Moussa, M., Croitoru, J., Menu, E., Dormont, D., Roques, P., Chaouat, G., 2000. HIV-1 
co-receptor expression on trophoblastic cells from early placentas and permissivity to 
infection by several HIV-1 primary isolates. Clin. Exp. Immunol. 119, 486–492. 
 
Mor, G., 2007. Macrophages and Pregnancy. The Role of T cells in Materno-Fetal Tolerance, in: 
Immunology of Pregnancy. Springer Science & Business Media, pp. 63–72; 171–178; 215–
228. 
 
Nagamatsu, T., Schust, D.J., 2010. Review: The Immunomodulatory Roles of Macrophages at the 
Maternal--Fetal Interface. Reprod. Sci. 17, 209–218. doi:10.1177/1933719109349962. 
 
Naldini, L., 1998. Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr. Opin. 
Biotechnol. 9, 457–463. doi:10.1016/S0958-1669(98)80029-3. 
 
NCIB, 2015. CD68 Molecule [Homo Sapiens (Humans)] [WWW Document]. Genes Expr. URL 
http://www.ncbi.nlm.nih.gov/gene/968 (accessed 9.16.15). 
 
Nyamweya, S., Hegedus, A., Jaye, A., Rowland-Jones, S., Flanagan, K.L., Macallan, D.C., 2013. 
Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis. Rev. Med. 
Virol. 23, 221–240. doi:10.1002/rmv.1739. 
 
Ochiel, D.O., Ochsenbauer, C., Kappes, J.C., Ghosh, M., Fahey, J.V., Wira, C.R., 2010. Uterine 
epithelial cell regulation of DC-SIGN expression inhibits transmitted/founder HIV-1 trans 
infection by immature dendritic cells. PloS One 5, e14306. 
doi:10.1371/journal.pone.0014306. 
 
Okoye, A.A., Picker, L.J., 2013. CD4 + T-cell depletion in HIV infection: mechanisms of 
immunological failure. Immunol. Rev. 254, 54–64. doi:10.1111/imr.12066. 
 
Olefsky, J.M., Glass, C.K., 2010. Macrophages, Inflammation, and Insulin Resistance. Annu. Rev. 
Physiol. 72, 219–246. doi:10.1146/annurev-physiol-021909-135846. 
 






Parry, S., Zhang, J., Koi, H., Arechavaleta-Velasco, F., Elovitz, M.A., 2006. Transcytosis of Human 
Immunodeficiency Virus 1 Across the Placenta Is Enhanced by Treatment with Tumour 
Necrosis Factor Alpha. J. Gen. Virol. 87, 2269–2278. doi:10.1099/vir.0.81071-0. 
 
Pillay, K., Cloete, M., McLeod, H., 2014. Expression of DC-SIGN and DC-SIGNRs in placentas of 
HIV-positive patients. South. Afr. J. HIV Med. 15, 97. doi:10.7196/sajhivmed.1094. 
 
Pöhlmann, S., Baribaud, F., Doms, R.W., 2001. DC-SIGN and DC-SIGNR: helping hands for HIV. 
Trends Immunol. 22, 643–646. doi:10.1016/S1471-4906(01)02081-6. 
 
Puigdomenech, I., Massanella, M., Izquierdo-Useros, N., Ruiz-Hernandez, R., Curriu, M., Bofill, M., 
Martinez-Picado, J., Juan, M., Clotet, B., Blanco, J., 2008. HIV transfer between CD4 T cells 
does not require LFA-1 binding to ICAM-1 and is governed by the interaction of HIV 
envelope glycoprotein with CD4. Retrovirology 5, 32. doi:10.1186/1742-4690-5-32. 
 
Puryear, W.B., Gummuluru, S., 2012. Role of Glycosphingolipids in Dendritic Cell-Mediated HIV-1 
Trans-infection, in: Wu, L., Schwartz, O. (Eds.), HIV Interactions with Dendritic Cells. 
Springer New York, New York, NY, pp. 131–153. 
 
Qian, Z.-D., Huang, L.-L., Zhu, X.-M., 2015. An immunohistochemical study of CD83-and CD1a-
positive dendritic cells in the decidua of women with recurrent spontaneous abortion. Eur. J. 
Med. Res. 20, 1–7. 
 
Read, J.S., American Academy of Pediatrics Committee on Pediatric AIDS, 2003. Human milk, 
breastfeeding, and transmission of human immunodeficiency virus type 1 in the United 
States. American Academy of Pediatrics Committee on Pediatric AIDS. Pediatrics 112, 1196–
1205. 
 
Romani, N., Clausen, B.E., Stoitzner, P., 2010. Langerhans cells and more: langerin-expressing 
dendritic cell subsets in the skin. Immunol. Rev. 234, 120–141. doi:10.1111/j.0105-
2896.2009.00886.x. 
 
Salamero, J., Bausinger, H., Mommaas, A.M., Lipsker, D., Proamer, F., Cazenave, J.P., Goud, B., de 
la Salle, H., Hanau, D., 2001. CD1a molecules traffic through the early recycling endosomal 
pathway in human Langerhans cells. J. Invest. Dermatol. 116, 401–408. doi:10.1046/j.1523-
1747.2001.01264.x 
 
Saving Mothers 2008-2010: Fifth Report on the Confidential Enquiries into Maternal Deaths in South 
Africa., 2010. . The South African National AIDS Council. 
 
Saving Mothers 2011- 2013: Sixth Report on the Confidential Enquiries into Maternal Deaths in 
South Africa, 2015. 
 
Schulke, L., Manconi, F., Markham, R., Fraser, I.S., 2008. Endometrial dendritic cell populations 







Sheikh, A.U., Polliotti, B.M., Miller, R.K., 2000. Human immunodeficiency virus infection: in situ 
polymerase chain reaction localization in human placentas after in utero and in vitro infection. 
Am. J. Obstet. Gynecol. 182, 207–213. 
 
Sica, A., Mantovani, A., 2012. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 
122, 787–795. doi:10.1172/JCI59643. 
 
Simister, N.E., Story, C.M., 1997. Human placental Fc receptors and the transmission of antibodies 
from mother to fetus. J. Reprod. Immunol. 37, 1–23. 
 
Soares, M.J., Hunt, J.S., 2006. Placenta and trophoblast: methods and protocols: overview II. Methods 
Mol. Med. 122, 3–7. 
 
Soilleux, E.J., Coleman, N., 2003. Transplacental transmission of HIV: a potential role for HIV 
binding lectins. Int. J. Biochem. Cell Biol. 35, 283–287. 
 
Soilleux, E.J., Morris, L.S., Lee, B., Pohlmann, S., Trowsdale, J., Doms, R.W., Coleman, N., 2001a. 
Placental expression of DC-SIGN may mediate intrauterine vertical transmission of HIV. J. 
Pathol. 195, 586–592. doi:10.1002/path.1026 
 
Stats SA, 2013. Millenium Developement Goals: Country Report 2013. Pretoria, South Africa. 
 
Steinman, R., 2015. Introduction to Dendritic Cells [WWW Document]. URL 
http://lab.rockefeller.edu/steinman/dendritic_intro/ (accessed 10.11.15). 
 
Strauss, J.H., Strauss, E.G., 2002. Viruses and human disease. Academic Press, San Diego. 
 
Sutton, L., Gadd, M., Mason, D.Y., Redman, C.W., 1986. Cells bearing class II MHC antigens in the 
human placenta and amniochorion. Immunology 58, 23–29. 
 
Svensson-Arvelund, J., Mehta, R.B., Lindau, R., Mirrasekhian, E., Rodriguez-Martinez, H., Berg, G., 
Lash, G.E., Jenmalm, M.C., Ernerudh, J., 2015. The Human Fetal Placenta Promotes 
Tolerance against the Semiallogeneic Fetus by Inducing Regulatory T Cells and Homeostatic 
M2 Macrophages. J. Immunol. 194, 1534–1544. doi:10.4049/jimmunol.1401536. 
 
Tassaneetrithep, B., Burgess, T.H., Granelli-Piperno, A., Trumpfheller, C., Finke, J., Sun, W., Eller, 
M.A., Pattanapanyasat, K., Sarasombath, S., Birx, D.L., Steinman, R.M., Schlesinger, S., 
Marovich, M.A., 2003. DC-SIGN (CD209) mediates dengue virus infection of human 
dendritic cells. J. Exp. Med. 197, 823–829. doi:10.1084/jem.20021840. 
 
Tenth Interim Report on Confidential Enquiries into Maternal Deaths in South Africa, 2011. . 
National Committee for Confidential Enquiries into Maternal Deaths. 
 
Thorbecke, G.J., Silberberg-Sinakin, I., Flotte, T.J., 1980. Langerhans cells as macrophages in skin 






TIEMESSEN, C.T., KUHN, L., 2006. Immune pathogenesis of pediatric HIV-1 infection. Curr. 
HIV/AIDS Rep. 3, 13–19. 
 
Trifonova, R.T., Lieberman, J., van Baarle, D., 2014. Distribution of immune cells in the human 
cervix and implications for HIV transmission. Am. J. Reprod. Immunol. N. Y. N 1989 71, 
252–264. doi:10.1111/aji.12198. 
 
Trkola, A., Dragic, T., Arthos, J., Binley, J.M., Olson, W.C., Allaway, G.P., Cheng-Mayer, C., 
Robinson, J., Maddon, P.J., Moore, J.P., 1996. CD4-dependent, antibody-sensitive 
interactions between HIV-1 and its co-receptor CCR-5. Nature 384, 184–187. 
doi:10.1038/384184a0. 
 
UN, 2015. Sustainable Development Goals. 
 
Vallen, C., Dorsamy, V., Moodley, J., Naicker, T., 2015. Immunolocalization of CCR-5 and ICAM-2 
expression in the placenta of normotensive and pre-eclamptic placentae. Placenta 36, A51. 
doi:10.1016/j.placenta.2015.07.341. 
 
Veenstra van Nieuwenhoven, A.L., 2003. The immunology of successful pregnancy. Hum. Reprod. 
Update 9, 347–357. doi:10.1093/humupd/dmg026. 
 
Vidricaire, G., Gauthier, S., Tremblay, M.J., 2007a. HIV‐1 Infection of Trophoblasts Is Independent 
of gp120/CD4 Interactions but Relies on Heparan Sulfate Proteoglycans. J. Infect. Dis. 195, 
1461–1471. doi:10.1086/515576. 
 
Vidricaire, G., Imbeault, M., Tremblay, M.J., 2004. Endocytic host cell machinery plays a dominant 
role in intracellular trafficking of incoming human immunodeficiency virus type 1 in human 
placental trophoblasts. J. Virol. 78, 11904–11915. doi:10.1128/JVI.78.21.11904-11915.2004. 
 
Vidricaire, G., Tardif, M.R., Tremblay, M.J., 2003. The Low Viral Production in Trophoblastic Cells 
Is Due to a High Endocytic Internalization of the Human Immunodeficiency Virus Type 1 
and Can Be Overcome by the Pro-inflammatory Cytokines Tumor Necrosis Factor-α and 
Interleukin-1. J. Biol. Chem. 278, 15832. 
 
Wang, Y., Zhao, S., 2010. Vascular Biology of the Placenta. Morgan & Claypool Life Sciences, San 
Rafael (CA). 
 
WHO, 2014. Mother to Child Transmission of HIV. WHO. 
 
WHO, UNICEF, UNFPA, 2014. Trends in Maternal Mortality: 1990 to 2013 (Executive Summary). 
Geneva, Switzerland. 
 
WHO, UNICEF, UNFPA, World Bank Group, United Nations Population Division, 2015. Maternal 






Yamashita, M., Emerman, M., 2006. Retroviral infection of non-dividing cells: old and new 












The aim of this study was to localize proteins such as DC-SIGN, CD68 and CD1a which have been 
implicated in HIV transmission from mother to child. Upon comparison, the results obtained from the 
HIV positive and HIV negative placentae showed that the expression of DC-SIGN was the same in both 
HIV negative as well as HIV positive samples. A similar observation was seen with regards to CD68 in 
the placental samples. The Langerhans cells on which CD1a give the idea that they are not present as 
no expression was noted in the HIV positive or the HIV negative placentae in this study. 
 
CD1a which is a specific marker of Langerhans cells is associated with the presentation of antigens to 
T cells (Mizumoto and Takashima, 2004). This CD1a protein is of biological importance as it mediates 
antigen presentation by an HLA-independent pathway (Schulke et al., 2008). Earlier studies have 
evaluated cells similar to those on which CD1a are found and have reported a decline in their presence 
as the pregnancy progressed. This study used term placenta which could possibly explain the lack of 
CD1a positive cells (Qian et al., 2015). Further studies looking at pre-term placenta would be beneficial 
as it is possible that CD1a positive cells could be involved in the initial infection by HIV after which 
other cell mediated mechanisms of HIV transmission may come into play. 
 
To support the theory of placental infection, it is important to note that during pregnancy, the apical 
aspect of the syncytiotrophoblast is in direct contact with infected maternal blood and is therefore 
exposed to HIV infected cells and cell free virus (Lagaye et al., 2001b). Expression of viral antigen in 
the chorionic membranes of the placenta has previously been reported in HIV-1 infected pregnant 
women (Sheikh et al., 2000) but immunolocalisation of HIV in the tissue was not clear (Arias et al., 
2003a). As stated by Mognetti et al (2000), infection of the placental cells requires the crossing  of HIV-
1 via the trophoblast layer into  the underlying cells and tissue for further infection. Although there has 
been in vitro studies to determine the ability of cell-free HIV to infect trophoblastic cells, results showed 
that the trophoblastic cells showed a resistance to the infection (David et al., 1992; Lagaye et al., 2001b). 
Extrapolating these results to model the in vivo situation compared to the in vitro conditions; for 
example, the cells used in these studies were unpolarised (David et al., 1992; Lagaye et al., 2001b) , 
could be a contributing factor to the supposed resistance to infection. Studies later on have proved that 
HIV transmission does enter trophoblast cells via endocytosis, as these cells have the ability to sustain 
virus production (Vidricaire et al., 2004, 2003). 
 
In the case of a normal pregnancy, of the immune cells found in placental tissue, approximately 70% of 





cells such as dendritic cells and macrophages which are derived from a common lymphocyte lineage 
are said to infiltrate the uterine decidua and amass themselves around the invading trophoblast cells 
(Ashkar et al., 2000). The importance of these cells in pregnancy has been made known through various 
studies which have shown that a decrease in dendritic cell populations have resulted in the lack of 
trophoblast invasion as well as decidual formation (Abrahams et al., 2004). With regards to the role of 
macrophages, amongst their other functions, they have been shown to play a pivotal role in the vascular 
remodelling within the uterine wall to ensure the appropriate utero-placental circulation (Nagamatsu 
and Schust, 2010). 
 
This study has presented evidence that CD68 is present on immune cells in the circulation of the mother 
as well as immune cells found within the fetal circulation. Specialized macrophages of the placenta 
known as Hofbauer cells have also been seen in HIV negative as well as HIV positive placental tissue. 
The absence of a significant difference in the number of CD68 positive cells in HIV infection compared 
to that of HIV negative samples as well as their involvement in HIV infection is suggestive of the fact 
that these cells could possibly provide a reservoir for HIV infection even where they are depleted T cell 
subsets in the progressed disease. Unlike the orthodox CD4+ T cells which are the primary targets of 
HIV, which decrease as the severity of the disease increases, macrophages are active from the initial 
placentation process and remain continuous throughout the pregnancy till parturition (Abrahams et al., 
2004). This seems to remain this way regardless of whether the mother is HIV positive or not. 
 
As important as macrophages are in various gestational processes, studies have shown that macrophages 
are able to be infected in vivo with HIV-1, resulting in both viral antigens as well as infectious virus in 
the culture supernatants (Kesson et al., 1993; McGann et al., 1994). 
 
Macrophages located in the placental decidua, which have been categorized according to the expression 
of CD68 and CD14, have been shown to express various C-type lectins on their cell surface. This 
provides them with the ability to distinguish between foreign ligands originating from microbes as well 
as those originating from endogenous microbes. Once such lectin is the dendritic cell-specific 
intracellular adhesion molecule 3 grabbing non-integrin (DC-SIGN); which was said to be first isolated 
and identified on immature dendritic cells (Nagamatsu and Schust, 2010). 
 
The DC-SIGN protein is said to be involved in the capture of microorganisms that enter and are found 
in mucosal tissue and migrate to secondary lymphoid organs where they present antigens of the 
microorganism to resting T cells, thereby initiating the adaptive immune response (Geijtenbeek et al., 
2000). The mechanism exploitation of the dendritic cells, on which DC-SIGN was first isolated, by HIV 
is still unclear but it has been found to be involved in a greater efficiency of infection of T cells 






The mechanism by which dendritic cells, on which DC-SIGN was first isolated, are said to be exploited 
by HIV is still unclear but it is said to increase efficiency of T cell infection. Previous studies have 
stated that DC-SIGN does not function as a receptor for the virus but rather supports the efficient in 
trans infection of T cells which express CD4 and chemokine receptors by increasing the concentration 
of virus at the dendritic cell surface (Geijtenbeek et al., 2000); while others have reported that the 
function of DC-SIGN is independent of the co-expression of CD4 and the associated appropriate 
receptors (Geijtenbeek et al., 2001). This theory is supported by studies which have shown that the viral 
gp120 protein which is used by HIV to enter T cells has a higher affinity for DC-SIGN compared to 
CD4 (Curtis et al., 1992; Geijtenbeek et al., 2000). This is further confirmed by studies which have 
shown that by obstructing the access to DC-SIGN, there has been a slight decrease in the transfer of 
HIV to T-cells and ultimately confirming the independent mechanisms of HIV transmission (Granelli-
Piperno et al., 2005). Together with this, DC-SIGN is able to capture HIV for more than four days 
which not only preserves its effectiveness but also provides the time needed to enter lymph node, as 
transport of the virus via dendritic cell movement only requires two days (Geijtenbeek et al., 2000). 
 
Given that all participants of this study were on some form of ARV treatment, it is important to establish 
the possible relationship between the two. Studies have further looked at the correlation between DC-
SIGN and its possible relationship with ARV treatment. It has been proposed that a cell-associated 
transmission mechanism has a higher efficiency in pregnancies where the viral load remains low due to 
ARV treatments such as HAART, as in utero transmission still occurs (Dorenbaum, 2001). Studies have 
reported DC-SIGN’s ability to greatly enhance infection in this instance which is of great importance 
in vertical transmission (Dorenbaum, 2001). As DC-SIGN has been localized on Hofbauer cells within 
the placenta, one of the proposed mechanisms by which DC-SIGN achieves this greater efficiency is 
said to be via the movement of infected Hofbauer cells into the umbilical cord vein which migrates 
directly into the fetus (Soilleux et al., 2001b). In the light of this, the importance of DC-SIGN cannot 
be overlooked. In this study, the expression of DC-SIGN was seen on immune cells in both the fetal 
and maternal circulation and in contrast to other studies (Pillay et al., 2014), also on the 
syncytiotrophoblast layer of both conducting as well as exchange placental villi.  
 
Various studies have provided evidence regarding DC-SIGN which support the theory whereby 
infection of the placenta takes place prior to the infection of the fetus. Due to the greater affinity of the 
gp120 protein for the DC-SIGN membrane protein (Geijtenbeek et al., 2000), it is plausible to believe 
that as a result of a greater expression of DC-SIGN on placental villi, a greater concentration of virus 
and viral particles may be found at these exchange barriers; allowing for a possible point of entry into 









In conclusion, this study demonstrates a similar DC-SIGN and CD68 immunolocalization profile as 
well as morphometry across HIV negative as well as HIV positive normotensive placentae. Moreover, 
we report an absence of antigen presenting Langerhans cells in the placenta. This study suggests that 
there is a possibility of an alternative mechanism of infection due to the correlation between normal 
immune function of these proteins, specifically DC-SIGN, and the ability of HIV to utilize and exploit 
these processes to its own advantage. It has been established that DC-SIGN has a higher efficiency 
attachment of HIV-1 when compared to the orthodox gp120 protein and as both DC-SIGN and CD68 
have been positively identified on decidual macrophages and Hofbauer cells, their presence could 
possibly provide a mechanism by which transmission may take place in the absence of the orthodox 
CD4+ receptor.  
 
The implication of DC-SIGN and CD68 as possible mechanisms of HIV transmission is supported by 
the results which indicate a continual presence of cells presenting these proteins throughout gestation 
(Abrahams et al., 2004; Soilleux et al., 2001b). We have seen that the number of cells which express 
these markers remain unchanged regardless of HIV status. As studies have proven the ease in which 
these proteins can be exploited, in the absence of orthodox receptors where HIV transmission to the 
baby has been reported, it is important to assess these proteins to determine the manner in which they 
successfully perform their immunological role and how this immunological role can be altered by which 
transmission could possibly result.  In this study we have seen that the HIV status of a mother does not 
alter the number of cells and quantity of expression of CD68 and DC-SIGN in normotensive pregnant 
women. With DC-SIGN positive Hofbauer cells possibly being able to travel from the mother via the 
umbilical vein to the fetus (Soilleux et al., 2001b), an increase in number of these cells expressing these 
proteins from placentation through to gestation is of great significance. Such expression provides 
evidence that HIV could use a cell-mediated pathway to enter the fetal circulation, or at least infect the 
fetomaternal barrier.  
 
As the participants of this study were on a form of ARV treatment, the effect of the treatment on the 
results obtained needed to be determined. Although ARV’s have greatly reduced HIV transmission, 
according to previous studies, it is possible that the implementation of ARV treatments such as HAART 
tend to direct HIV infection towards a cell-associated mechanism as there appears to be a higher 
efficiency of the vertical transmission of HIV in cases where viral loads remain low.  
If the function of DC-SIGN is minimal when the viral load is reported low, it is plausible to assume that 






In conclusion, we found that the expression of the DC-SIGN and CD68 proteins as markers on immune 
cells appear to be unaffected by the HIV status of a patient or the administration of ARV treatment. 
3.3. Recommendations 
 
The CD68 and DC-SIGN proteins investigated in this study play a role in HIV transmission yet their 
connection to one another is not clearly understood. It is a possibility that the mechanism by which 
HIV-1 infects trophoblast cells incorporates both the conventional as well as the non-conventional 
receptor routes in order for transmission to occur by effectively exploiting these proteins to mediate 
successful entry. For further studies, confirmatory tests to isolate markers of HIV infection within these 
cells would provide valuable insight into their role in transmission. By being able to identify the 
association of these proteins with placentae at varying stages of gestation as well as the immunological 
phenotype, we will be able to elucidate their role not only in transmission of HIV but also their activity 
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